Clinical trials
Egg Allergy clinical trials
Below are recruiting egg allergy clinical trials, each written for real people, not researchers. We’re tracking 7 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06260956Recruiting
Peanut and egg study for expecting mothers
This study looks at whether eating or avoiding peanuts and eggs during pregnancy can affect the baby's risk of allergies. You and your baby will be followed for a year after birth.
Rochester, New YorkAges 1 day+ - NCT05740163Recruiting
Oral treatment to help children with egg allergy
This trial tests an oral (by mouth) immune-based treatment to reduce egg allergy reactions in children ages 6 to 16. It may help some kids become more tolerant to egg, but it requires careful screening and follow-through.
OuluAges 6–16 - NCT06976775RecruitingPhase 2/Phase 3
Comparing two oral immunotherapy methods for milk and egg allergy
This study compares two ways of doing oral immunotherapy (gradually eating more of the allergen) for children with cow's milk or hen's egg allergy. It aims to find which method is safer and works better.
MadridAges 6–16 - NCT07359183Recruiting
Long-term follow-up of kids who had oral immunotherapy for allergies
This study checks on children and young people 5 to 15 years after they finished an 18-month oral immunotherapy treatment for peanut, egg, or milk allergy. It helps researchers understand how their allergies and health are doing over the long term.
Parkville, VictoriaAges Any age - NCT07768371RecruitingPhase 3
Remibrutinib for peanut, milk, or egg allergies
This study tests an investigational drug called remibrutinib to see if it can reduce allergic reactions to peanuts, milk, or eggs. It is for people aged 12 to 65 who have been diagnosed with a food allergy and are willing to participate in food challenges.
Los Angeles, CaliforniaAges 12–65 - NCT06256146Recruiting
Treating food allergies with modified oral immunotherapy
This study tests a new approach to oral immunotherapy for food allergies, aiming to make it safer and more effective. It's for people who have had a clear allergic reaction to a food and have a positive allergy test.
Montreal, QuebecAges 2–40 - NCT07419243RecruitingPhase 1/Phase 2
Tolerance in milk and egg allergy in children
This study watches how milk and egg allergies change naturally over time or after oral immunotherapy (OIT) in children. It helps researchers understand how the immune system adapts, aiming to improve treatment for food allergies.
Madrid, MadridAges 4–17
Hear when a new Egg Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for egg allergy?
- Yes. Clin2 currently lists 7 recruiting egg allergy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a egg allergy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a egg allergy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.